On the heels of an already ambitious $100 million expansion plan, Catalent Incorporated has upped the ante by another $100 million. Catalent will invest $100 million in its bulk biological site in Madison, Wisconsin, with the other $100 million going to the Bloomington, Indiana, site. The company bought the 875,000-square-foot Blooomington site last year from Cook Pharmica for $950 million to further expand into biological contract manufacturing.
/iirenergy/industry-news/article.jsp
Want More IIR News?
Make us a Preferred Source on Google to see more of us when you search.
Add Us On Google
Loading...
Refer This Article
Ask Us
Have a question for our staff?
Submit a question and one of our experts will be happy to assist you.
Explore Our EnergyLive Tools
EnergyLive Tools provide instant insight into new build, outages, maintenance, and capacity shifts across key energy sectors.
Learn MoreRelated Articles
-
Novo Nordisk Spends $11 Billion to Make More Weight Loss Dru...February 15, 2024
-
EU Adds New COVID-19 Manufacturing CapacitySeptember 07, 2021
-
ISPE Names the 2017 Pharmaceutical Facility of the Year Cate...February 07, 2017
Explore Our Enery Industry Reports
Gain the competitive edge with IIR Energy’s suite of energy market reports, designed for traders, analysts, and asset managers who rely on verified, real-time data.
Learn MoreIndustry Intel
-
From Data to Decisions: How IIR Energy Helps Navigate Market VolatilityOn-Demand Podcast / Nov. 18, 2025
-
Navigating the Hydrogen Horizon: Trends in Blue and Green EnergyOn-Demand Podcast / Nov. 3, 2025
-
ESG Trends & Challenges in Latin AmericaOn-Demand Podcast / Nov. 3, 2025
-
2025 European Transportation & Biofuels Spending OutlookOn-Demand Podcast / Oct. 27, 2025
-
2025 Global Oil & Gas Project Spending OutlookOn-Demand Podcast / Oct. 24, 2025